apposters.com
Kedrion Biopharma
Edit

Kedrion Biopharma

https://www.kedrion.com/
Last activity: 16.07.2026
Active
Categories: BusinessContent DistributionDevelopmentEnterpriseHealthTechIndustryITMaterialsMedtechProduction
Kedrion Biopharma collects and fractionates blood plasma for the development, production and distribution of plasma derivatives used in the treatment of patients suffering from rare and chronic conditions such as hemophilia and immune system deficiencies.

A corporation is not a person, but a corporation is run by people and it affects people. And Kedrion’s business is people. The very nature of our enterprise is to help people live more full and healthy lives. This commitment extends to how we conduct our business, that is, in ways that are consistent with our mission: to build bridges that benefit people.

Long a major player in the plasma derivatives sector in Italy, as partner with the Italian Health System, Kedrion has now become an international participant in the industry with a market presence in 100 countries. We have plants in Italy, Hungary and the United States and plasma collection centers in the US.

Our goal is to build a diverse and professional workforce, providing job opportunities for talented external candidates as well as internal employees who aim to grow with us. Because our work includes so many interests and skills – from Research to Sales; Plasma Collection to Production – there are abundant possibilities for learning and growth. Kedrion Biopharma builds bridges: from donors to patients, from plasma to therapies, from challenge to hope.

A note about our informational, marketing, and promotional materials. We try to bring our mission, our values, and our work “to life” with stories about “real” people: actual donors, patients, our employees. We have traveled around the world to collect these stories and have had the privilege of meeting extraordinary people generously willing to open and share their lives. We are fortunate to have found a talented and highly regarded photographer; Christian Sinibaldi is responsible for most of the fine photographs you will find in our materials.
Website visits
23.4K /mo.
Mentions
12
Location: Italy, Tuscany, Lucca
Employees: 1001-5000
Founded date: 2001

Mentions in press and media 12

DateTitleDescription
20.07.2026InstaLILY Secures $60 Million Series B to Accelerate AI Enterprise RevolutionInstaLILY secured $60 million in Series B funding, boosting its total capital to nearly $100 million. Energize Capital led the round, joined by Insight Partners, Home Depot Ventures, and United Rentals. The New York-based firm's AI, Lily, r...
16.07.2026InstaLILY Raises $60M in Series B FundingInstaLILY, a New York City-based developer of enterprise AI forward-deployed engineering software and small data center infrastructure, raised $60m in Series B funding. The round was led by Energize Capital, with participation from Insight ...
14.07.2026InstaLILY Raises $60 Million Series B And Launches Lily As An AI Forward Deployed EngineerInstaLILY AI, creator of the world’s first AI Forward Deployed Engineer, announced a $60 million Series B round led by Energize Capital, with participation from Insight Partners, which increased its investment, and new strategic investors i...
17.04.2026World Hemophilia Day 2026 - April 17, 2026 - "Diagnosis: First step to care."MONTREAL, April 17, 2026 /PRNewswire/ -- On April 17, 2026, the global inherited bleeding disorders community will come together on World Hemophilia Day to advocate for all inherited bleeding disorders. This year's theme of "Diagnosis:...
30.03.2026AvevoRx Selected as a Network Specialty Pharmacy for Nationwide Launch of Kedrion's QIVIGY® IVIG TherapyParticipation highlights AvevoRx's expanding national reach and leadership in delivering complex infusion therapies to patients across the U.S. GREENSBORO, N.C., March 30, 2026 /PRNewswire-PRWeb/ -- AvevoRx, a leading national, independent ...
17.04.2025World Hemophilia Day 2025 - April 17, 2025 - "Access for all: Women and girls bleed too"MONTREAL, April 17, 2025 /PRNewswire/ -- On April 17, 2025, the global bleeding disorders community will come together under the theme "Access for all: Women and girls bleed too" and celebrate World Hemophilia Day. Today, women an...
01.07.2024Kedrion Selected by Biotest to Distribute its Immunoglobulin Yimmugo® in the U.S. Following Recent FDA ApprovalCASTELVECCHIO PASCOLI, Italy, July 1, 2024 /PRNewswire/ -- Kedrion Biopharma Inc. announced today that it has established the framework for a long-term agreement with Biotest AG for the full commercialization and distribution of the immunog...
17.04.2024World Hemophilia Day 2024"Equitable access for all: recognizing all bleeding disorders"MONTREAL, April 17, 2024 /PRNewswire/ -- On April 17, 2024, the global bleeding disorders community will come together to celebrate World Hemophilia Day. The theme of the event this year is "Equitable access for all: recognizing all bl...
01.06.2011Grifols and Talecris get FTC approval to mergeThe FTC had been concerned that a merger of two of the top companies in the specialized blood therapeutics space would hurt competition and lead to higher drug costs for patients. The FTC raised antitrust concerns in 2009 when it blocked a ...
02.05.2011Talecris-Grifols merger wins preliminary FTC approvalThe consent agreement is still subject to approval by FTC commissioners. FTC officials had been concerned that the acquisition of Research Triangle Park, North Carolina-based Talecris would reduce competition and raise prices for drugs in t...
Show more

Reviews 0

Sign up to leave a review

Sign up Log In